Simon Quick Advisors LLC lowered its stake in Danaher Co. (NYSE:DHR – Free Report) by 7.2% in the first quarter, HoldingsChannel.com reports. The firm owned 4,055 shares of the conglomerate’s stock after selling 314 shares during the quarter. Simon Quick Advisors LLC’s holdings in Danaher were worth $831,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Zhang Financial LLC boosted its position in shares of Danaher by 3.6% in the 1st quarter. Zhang Financial LLC now owns 1,774 shares of the conglomerate’s stock worth $364,000 after purchasing an additional 62 shares during the last quarter. Alpha Omega Wealth Management LLC boosted its holdings in shares of Danaher by 1.6% in the first quarter. Alpha Omega Wealth Management LLC now owns 14,646 shares of the conglomerate’s stock valued at $3,002,000 after buying an additional 229 shares during the period. McKinley Carter Wealth Services Inc. increased its holdings in Danaher by 2.8% during the 1st quarter. McKinley Carter Wealth Services Inc. now owns 3,004 shares of the conglomerate’s stock worth $616,000 after purchasing an additional 81 shares in the last quarter. Curbstone Financial Management Corp raised its position in Danaher by 11.2% in the 1st quarter. Curbstone Financial Management Corp now owns 3,966 shares of the conglomerate’s stock valued at $813,000 after buying an additional 400 shares during the last quarter. Finally, CX Institutional lifted its position in shares of Danaher by 11.2% in the first quarter. CX Institutional now owns 3,304 shares of the conglomerate’s stock worth $677,000 after purchasing an additional 334 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.
Wall Street Analyst Weigh In
A number of research analysts have weighed in on the company. Jefferies Financial Group decreased their price target on Danaher from $260.00 to $230.00 and set a “buy” rating for the company in a research note on Tuesday, April 22nd. TD Cowen increased their price objective on Danaher from $240.00 to $248.00 and gave the stock a “buy” rating in a research report on Wednesday, April 23rd. HSBC reduced their price target on Danaher from $270.00 to $240.00 in a research report on Friday, April 25th. Leerink Partners upped their price target on shares of Danaher from $225.00 to $230.00 and gave the stock an “outperform” rating in a report on Wednesday, April 23rd. Finally, UBS Group decreased their target price on Danaher from $275.00 to $240.00 and set a “buy” rating on the stock in a research report on Wednesday, April 23rd. Five investment analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $248.17.
Danaher Trading Up 0.1%
DHR opened at $204.85 on Friday. The stock has a market cap of $146.60 billion, a PE ratio of 38.80, a price-to-earnings-growth ratio of 2.66 and a beta of 0.77. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. The company has a fifty day moving average of $192.27 and a 200-day moving average of $211.44. Danaher Co. has a twelve month low of $171.00 and a twelve month high of $281.70.
Danaher (NYSE:DHR – Get Free Report) last announced its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, beating analysts’ consensus estimates of $1.62 by $0.26. Danaher had a return on equity of 10.82% and a net margin of 16.33%. The firm had revenue of $5.74 billion during the quarter, compared to analysts’ expectations of $5.58 billion. On average, sell-side analysts predict that Danaher Co. will post 7.63 EPS for the current year.
Danaher Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be given a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 0.62%. Danaher’s dividend payout ratio is currently 24.85%.
Insider Transactions at Danaher
In other Danaher news, Chairman Steven M. Rales sold 1,250,000 shares of the firm’s stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $196.74, for a total value of $245,925,000.00. Following the completion of the transaction, the chairman now owns 3,105,808 shares in the company, valued at $611,036,665.92. This trade represents a 28.70% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Christopher Paul Riley sold 15,805 shares of the company’s stock in a transaction on Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the completion of the transaction, the executive vice president now directly owns 15,179 shares in the company, valued at approximately $3,005,442. The trade was a 51.01% decrease in their position. The disclosure for this sale can be found here. Company insiders own 11.10% of the company’s stock.
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Articles
- Five stocks we like better than Danaher
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Ignore the Noise—Samsara Stock Is Still a Strong Buy
- Insider Trading – What You Need to Know
- 3 Stocks Set to Double—And There’s Still Time to Buy
- Where to Find Earnings Call Transcripts
- Analysts Can’t Get Enough of These Little-Known Biopharma Stocks
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.